The Facebook Inovio group was taking about it. It appears that Roche is in a deal with a company in Seattle on Prostate - so not sure what is in play except that Inovio deciding to go on with P1 in first quarter says that whatever Roche had, they either didn't need it or didn't want it to continue this. Good decision. I trust Kim completely on knowing the path they are taking and what is most advantageous. I also suspect that by the end of the year there might very well be a new partner for that deal before first quarter, someone who has either the cash or the technology that INO needs to make it awesome.
News 
Market Data 
Discover 
